A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer
Clinical trial NCT05812677 · UNKNOWN
Trial details
- NCT number
- NCT05812677
- Sponsor
- Shanghai Yunying Medical Technology
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2025-02-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.